Cognitive sequelae of endocrine therapy in women treated for breast cancer: a meta-analysis

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Breast Cancer Research and Treatment

• Publication date

  2018-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10549-017-4627-4PMID 29264751
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Why estrogens matter for behavior and brain health

  2017cited by this paper
• Treatments for Breast Cancer That Affect Cognitive Function in Postmenopausal Women

  2017cited by this paper
• Endocrine treatment-associated cognitive impairment in breast cancer survivors: evidence from published studies

  2016cited by this paper
• Memory and Spatial Cognition in Breast Cancer Patients Undergoing Adjuvant Endocrine Therapy

  2016cited by this paper
• Cognitive functioning during long-term tamoxifen treatment in postmenopausal women with breast cancer

  2015cited by this paper
• Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.

  2015cited by this paper
• ENDOCRINE DILEMMA: Managing menopausal symptoms after breast cancer.

  2015cited by this paper
• A phase III randomized multicenter trial evaluating cognition in post-menopausal breast cancer patients receiving adjuvant hormonotherapy

  2015cited by this paper
• Verbal memory and menopause.

  2015cited by this paper
• Cognitive effects of endocrine therapy for breast cancer: keep calm and carry on?

  2015cited by this paper
• Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update.

  2014cited by this paper
• Breast cancer statistics, 2013

  2014cited by this paper
• Baseline cognitive functions among elderly patients with localised breast cancer.

  2014cited by this paper
• Cognitive function after the initiation of adjuvant endocrine therapy in early-stage breast cancer: an observational cohort study.

  2014cited by this paper
• Cognitive dysfunctions in elderly cancer patients: a new challenge for oncologists.

  2014cited by this paper
• Cognitive effects of cancer systemic therapy: implications for the care of older patients and survivors.

  2014cited by this paper
• Decision-making impairments in breast cancer patients treated with tamoxifen.

  2014cited by this paper
• Lifelong Estrogen Exposure and Memory in Older Postmenopausal Women

  2013cited by this paper
• HER2 status in elderly women with breast cancer.

  2013cited by this paper
• Breast Cancer Statistics

  2013cited by this paper
• Menopause effects on verbal memory: findings from a longitudinal community cohort.

  2013cited by this paper
• Is Statin-Associated Cognitive Impairment Clinically Relevant? A Narrative Review and Clinical Recommendations

  2012cited by this paper
• Effects of adjuvant treatment on cognitive function in women with early breast cancer.

  2012cited by this paper
• Scoring Higher the Second Time Around: Meta-Analyses of Practice Effects in Neuropsychological Assessment

  2012cited by this paper
• Cancer- and cancer treatment-associated cognitive change: an update on the state of the science.

  2012cited by this paper
• Chemotherapy-Related Cognitive Dysfunction

  2012cited by this paper
• Cognitive limitations associated with tamoxifen and aromatase inhibitors in employed breast cancer survivors

  2012cited by this paper
• International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer.

  2011cited by this paper
• Incidence of breast cancer in the United States: current and future trends.

  2011cited by this paper
• Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

  2011cited by this paper
• Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve.

  2010cited by this paper
• Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial.

  2010cited by this paper
• Endocrine therapy is associated with low performance on some estrogen-sensitive cognitive tasks in postmenopausal women with breast cancer

  2010cited by this paper
• Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study

  2010cited by this paper
• Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study

  2009cited by this paper
• A randomized double-blind trial of the effects of hormone therapy on delayed verbal recall in older women.

  2009cited by this paper
• Cognitive toxicity of pharmacotherapeutic agents used in social anxiety disorder

  2009cited by this paper
• Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: Cross-sectional findings from the neuropsychological TEAM-side study

  2009cited by this paper
• Cognitive effects of Tamoxifen in pre-menopausal women with breast cancer compared to healthy controls

  2008cited by this paper
• Endogenous sex hormone levels and risk of cognitive decline in an older biracial cohort.

  2007cited by this paper
• Exemestane's 17-hydroxylated metabolite exerts biological effects as an androgen

  2007cited by this paper
• Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment

  2007cited by this paper
• Aromatase inhibitors: a time for reflection.

  2007cited by this paper
• Does cognitive impairment after chemotherapy for breast cancer improve over time or does practice make perfect?

  2006cited by this paper
• SSRIs and cognitive performance in a working sample

  2005cited by this paper
• The effects of benzodiazepines on cognition.

  2005cited by this paper
• Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years

  2005cited by this paper
• Serum levels of estradiol and testosterone and performance in different cognitive domains in healthy elderly men and women.

  2004cited by this paper
• Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study

  2004cited by this paper
• Prediction of transition from cognitive impairment to senile dementia: a prospective, longitudinal study

  2003cited by this paper
• Measuring inconsistency in meta-analyses

  2003cited by this paper
• Endogenous estradiol and testosterone levels are associated with cognitive performance in older women and men.

  2002cited by this paper
• Enhanced verbal memory in nondemented elderly women receiving hormone-replacement therapy.

  2001cited by this paper
• Associations between circulating sex steroid hormones and cognition in normal elderly women

  2000cited by this paper
• Prediction of probable Alzheimer's disease in memory-impaired patients

  1996cited by this paper
• Estrogen Use and Verbal Memory in Healthy Postmenopausal Women

  1994cited by this paper
• Effects of estrogen on memory function in surgically menopausal women.

  1992cited by this paper
• Estrogen and Cognitive Functioning in Surgically Menopausal Women a

  1990cited by this paper
• Statistical Methods for Meta-Analysis

  1987cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper

• Age-stratified analysis of health-related quality of life in patients with early-stage breast cancer receiving adjuvant radiation therapy and endocrine therapy.

  2025cites this paper
• Improving detection of cancer-related cognitive impairment (CRCI) in non-CNS cancer: current trends and future directions

  2025cites this paper
• Comorbid symptoms in cancer patients and caring for the caregiver

  2025cites this paper
• Factors affecting daily activities in premenopausal breast cancer patients undergoing endocrine therapy.

  2025cites this paper
• The risk of dementia in breast cancer survivors: a meta-analysis of observational studies

  2025cites this paper
• Neuropsychological functioning in non-CNS cancer patients

  2025cites this paper
• Impact cognitif du cancer du sein et de ses traitements et modalités de prise en soins

  2025cites this paper
• Long-term health-related quality of life among adolescent and young adult breast cancer survivors

  2025cites this paper
• Interaction between APOE Ɛ4 status, chemotherapy and endocrine therapy on cognitive functioning among breast cancer survivors: the CANTO-Cog longitudinal study

  2025cites this paper
• Cognitive impairment following breast cancer treatments: an umbrella review

  2024influential citation
• Exploring the role of sex hormones and gender diversity in multiple sclerosis

  2024cites this paper
• Effects of tamoxifen on cognitive function in patients with primary breast cancer

  2024cites this paper
• Rapid and local neuroestrogen synthesis supports long‐term potentiation of hippocampal Schaffer collaterals‐cornu ammonis 1 synapse in ovariectomized mice

  2024cites this paper
• Computerized cognitive training improves cognitive function in primary breast cancer survivors

  2024cites this paper
• A systematic review of rehabilitation programs for cognitive impairment related to breast cancer: Different programs at different times?

  2024cites this paper
• Refining and optimising a behavioural intervention to support endocrine therapy adherence (ROSETA) in UK women with breast cancer: protocol for a pilot fractional factorial trial

  2023cites this paper
• Hormonal Therapies in Multiple Sclerosis: a Review of Clinical Data

  2023cites this paper
• Optimal adjuvant therapy in older (≥70 years of age) women with low-risk early-stage breast cancer

  2023cites this paper
• Neurocognitive impairment in females with breast cancer treated with endocrine therapy and CDK4/6 inhibitors: a pharmacovigilance study using the World Health Organization’s database

  2023cites this paper
• Long-Term Oral Tamoxifen Administration Decreases Brain-Derived Neurotrophic Factor in the Hippocampus of Female Long-Evans Rats

  2023cites this paper
• Effects of Tai Chi Chuan training on the QoL and psychological well-being in female patients with breast cancer: a systematic review of randomized controlled trials

  2023cites this paper
• Effectiveness of a Computerized Home-Based Cognitive Stimulation Program for Treating Cancer-Related Cognitive Impairment

  2023cites this paper
• Cognitive impairment after cancer treatment: mechanisms, clinical characterization, and management

  2023cites this paper
• Cognitive decline in patients of breast cancer at Sohag University Hospital

  2023cites this paper
• Neuro-immune-endocrine mechanisms with poor adherence to aromatase inhibitor therapy in breast cancer

  2022cites this paper
• Supporting adjuvant endocrine therapy adherence in women with breast cancer: the development of a complex behavioural intervention using Intervention Mapping guided by the Multiphase Optimisation Strategy

  2022cites this paper
• Cognitive adverse effects of chemotherapy and immunotherapy: are interventions within reach?

  2022cites this paper
• Gynecological management of the breast cancer survivor.

  2022cites this paper
• Telerehabilitation for Managing Daily Participation among Breast Cancer Survivors during COVID-19: A Feasibility Study

  2022cites this paper
• Comorbidity of Osteoporosis and Alzheimer's Disease: Is `AKT `-ing on Cellular Glucose Uptake the Missing Link?

  2022cites this paper
• Cancer treatment regimens and their impact on the patient-reported outcome measures health-related quality of life and perceived cognitive function

  2022cites this paper
• Multimodal MRI examination of structural and functional brain changes in older women with breast cancer in the first year of antiestrogen hormonal therapy

  2022cites this paper
• Psychische Langzeitfolgen von Krebserkrankungen

  2022cites this paper
• Long-term changes of cognitive impairment among older breast cancer survivors

  2022cites this paper
• Association of raloxifene and tamoxifen therapy with cognitive performance, odds of mild cognitive impairment, and brain MRI markers of neurodegeneration

  2022cites this paper
• Sleep-dependent memory consolidation in breast cancer: Use of a virtual reality prospective memory task

  2022cites this paper
• Perioperative considerations in patients with chemotherapy-induced cognitive impairment: a narrative review.

  2022cites this paper
• Neurologic complications of breast cancer

  2022cites this paper
• Facing points of view: Representations on adjuvant endocrine therapy of premenopausal patients after breast cancer and their healthcare providers in France. The FOR-AD study.

  2022cites this paper
• Codevelopment of a Text Messaging Intervention to Support Adherence to Adjuvant Endocrine Therapy in Women With Breast Cancer: Mixed Methods Approach

  2022cites this paper
• Multimodal MRI examination of structural and functional brain changes in older women with breast cancer in the first year of antiestrogen hormonal therapy

  2022cites this paper
• Effects of tamoxifen on cognition and language in women with breast cancer: A systematic search and a scoping review

  2021cites this paper
• Patterns of Sequelae in Women with a History of Localized Breast Cancer: Results from the French VICAN Survey

  2021cites this paper
• Perspectives and limits of cancer treatment in an oldest old population

  2021cites this paper
• Meta-analysis of the DeLone and McLean models in e-learning success: the moderating role of user type

  2021cites this paper
• Routine Cancer Treatment Regimens and Its Impact on Fine Motor Dexterity in Breast Cancer

  2021cites this paper
• Focal white matter microstructural alteration after anthracycline-based systemic treatment in long-term breast cancer survivors: a structural magnetic resonance imaging study

  2021cites this paper
• Endocrine Therapy With or Without CDK4/6 Inhibitors in Women With Hormone-receptor Positive Breast Cancer: What do we Know About the Effects on Cognition?

  2021cites this paper
• De-escalation of Endocrine Therapy in Early Hormone Receptor-positive Breast Cancer

  2021cites this paper
• Neuron-Derived Estrogen—A Key Neuromodulator in Synaptic Function and Memory

  2021cites this paper
• Structural Neuroimaging Findings Related to Adult Non-CNS Cancer and Treatment: Review, Integration, and Implications for Treatment of Cognitive Dysfunction

  2021cites this paper
• EFFECTS OF LETROZOLE ON MICRORNAS: IMPLICATIONS ON MEMORY AND ALZHEIMER’S DISEASE

  2021cites this paper
• Trajectories of cognitive performance over five years in a prospective cohort of patients with breast cancer (NEON-BC)

  2021cites this paper
• Le sommeil dans les cancers non cérébraux : revue de la littérature, mécanismes potentiels et perspectives pour mieux comprendre les troubles cognitifs associés

  2021cites this paper
• Brain-derived estrogen and neural function

  2021cites this paper
• Self-reported cognitive decline in Japanese patients with breast cancer treated with endocrine therapy

  2020cites this paper
• Experience of Developing a Cognitive Exercise Program in Patients Screened for Breast Cancer - A Pilot Study

  2020cites this paper
• „Chemobrain“? Beeinträchtigungen kognitiver Funktionen bei Mammakarzinompatientinnen

  2020influential citation
• Perceived Cognitive Impairment in Breast Cancer Survivors and Its Relationships with Psychological Factors

  2020cites this paper
• Neuropsychiatric Effects of Tamoxifen: Challenges and Opportunities.

  2020cites this paper
• Aromatase Inhibitors—Induced Musculoskeletal Disorders: Current Knowledge on Clinical and Molecular Aspects

  2020cites this paper
• Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx.

  2020cites this paper
• ESO-ESMO 4rd International Consensus Guidelines for Breast Cancer in Young Women (BCY4).

  2020cites this paper
• Endocrine Treatment of Young Patients with EBC

  2020cites this paper
• Endocrine Therapy for Hormone Receptor‐Positive Breast Cancer

  2019cites this paper
• Chemobrain ? Beeinträchtigungen kognitiver Funktionen bei Mammakarzinompatientinnen

  2019influential citation
• Cognitive Functioning and Psychological Well-being in Breast Cancer Patients on Endocrine Therapy

  2019cites this paper
• A daganatos betegséggel összefüggő kognitív hanyatlás és annak vizsgálómódszerei

  2019cites this paper
• Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK

  2019cites this paper
• Cardiovascular and Central Nervous System Toxicity by Anticancer Drugs in Breast Cancer Patients

  2019cites this paper
• Long-Term Fatigue and Cognitive Disorders in Breast Cancer Survivors

  2019cites this paper
• Cognitive effects of adjuvant endocrine therapy in older women treated for early-stage breast cancer: a 1-year longitudinal study

  2019cites this paper
• Neuron-Derived Estrogen Regulates Synaptic Plasticity and Memory

  2019cites this paper
• „Chemobrain“? Beeinträchtigungen kognitiver Funktionen bei Mammakarzinompatientinnen

  2019cites this paper
• An Integrated Analysis of Risk Factors of Cognitive Impairment in Patients with Severe Carotid Artery Stenosis.

  2018cites this paper
• Reply to K. Altundag

  2018cites this paper
• The cognitive effects of endocrine therapy in survivors of breast cancer: A prospective longitudinal study up to 6 years after treatment

  2018cites this paper
• Detailed information about chemotherapy in breast control arm might affect cognitive sequelae compared with endocrine therapy patients

  2018cites this paper
• Cognitive Effects of Aromatase and Possible Role in Memory Disorders

  2018cites this paper
• Impact of breast cancer on prospective memory functioning assessed by virtual reality and influence of sleep quality and hormonal therapy: PROSOM-K study

  2018cites this paper